The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy
Open accessAbstract
Recent reports have challenged the notion that retroviruses and retroviral vectors integrate randomly into the host genome. These reports pointed to a strong bias toward integration in and near gene coding regions and, for gammaretroviral vectors, around transcription start sites. Here, we report the results obtained from a large-scale mapping of 572 retroviral integration sites (RISs) isolated from cells of 9 patients with X-linked SCID (SCID-X1) treated with a retrovirus-based gene therapy protocol. Our data showed that two-thirds of insertions occurred in or very near to genes, of which more than half were highly expressed in CD34(+) progenitor cells. Strikingly, one-fourth of all integrations were clustered as common integration sites (CISs). The highly significant incidence of CISs in circulating T cells and the nature of their locations indicate that insertion in many gene loci has an influence on cell engraftment, survival, and proliferation. Beyond the observed cases of insertional mutagenesis in 3 patients, these data help to elucidate the relationship between vector insertion and long-term in vivo selection of transduced cells in human patients with SCID-X1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Self-citationGene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
Self-citationHIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Statistical Methods in Medical Research
Armitage, P., Berry, G., & Matthews, J. N. S. (2002) · Wiley eBooks · doi:10.1002/9780470773666 · Cited by 1,630
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305
Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.-P., Thrasher, A. J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012616 · Cited by 1,058
Self-citationOtt, M. G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kühlcke, K., Schilz, A., Kunkel, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1393 · Cited by 1,051
Self-citationRetroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 976
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., et al. (2002) · Science · doi:10.1126/science.1070104 · Cited by 975
Gaspar, H. B., Parsley, K. L., Howe, S., King, D., Gilmour, K. C., Sinclair, J., Brouns, G., Schmidt, M., Von Kalle, C., Barington, T., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17590-9 · Cited by 689
Self-citationAdvances in biology of multiple myeloma: clinical applications
Hideshima, T., Bergsagel, P. L., Kuehl, W. M., & Anderson, K. C. (2004) · Blood · doi:10.1182/blood-2004-01-0037 · Cited by 582
New genes involved in cancer identified by retroviral tagging
Suzuki, T., Shen, H., Akagi, K., Morse, H. C., Malley, J. D., Naiman, D. Q., Jenkins, N. A., & Copeland, N. G. (2002) · Nature Genetics · doi:10.1038/ng949 · Cited by 420
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer
Mikkers, H., Allen, J., Knipscheer, P., Romeyn, L., Hart, A., Vink, E., & Berns, A. (2002) · Nature Genetics · doi:10.1038/ng950 · Cited by 377
Dik, W. A., Pike-Overzet, K., Weerkamp, F., de Ridder, D., de Haas, E. F. E., Baert, M. R. M., van der Spek, P., Koster, E. E. L., Reinders, M. J. T., van Dongen, J. J. M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042524 · Cited by 335
Self-citationClonal dominance of hematopoietic stem cells triggered by retroviral gene marking
Kustikova, O., Fehse, B., Modlich, U., Yang, M., Düllmann, J., Kamino, K., von Neuhoff, N., Schlegelberger, B., Li, Z., & Baum, C. (2005) · Science · doi:10.1126/science.1105063 · Cited by 283
Hematti, P., Hong, B.-K., Ferguson, C., Adler, R., Hanawa, H., Sellers, S., Holt, I. E., Eckfeldt, C. E., Sharma, Y., Schmidt, M., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020423 · Cited by 265
Self-citationGenome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice
Lund, A. H., Turner, G., Trubetskoy, A., Verhoeven, E., Wientjens, E., Hulsman, D., Russell, R., DePinho, R. A., Lenz, J., & van Lohuizen, M. (2002) · Nature Genetics · doi:10.1038/ng956 · Cited by 230
Bushman, F. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00760-8 · Cited by 221
Polyclonal long-term repopulating stem cell clones in a primate model
Schmidt, M. (2002) · Blood · doi:10.1182/blood-2002-02-0407 · Cited by 218
Self-citationTranscriptionally active genome regions are preferred targets for retrovirus integration
Scherdin, U., Rhodes, K., & Breindl, M. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.907-912.1990 · Cited by 210
Schwarzwaelder, K., Howe, S. J., Schmidt, M., Brugman, M. H., Deichmann, A., Glimm, H., Schmidt, S., Prinz, C., Wissler, M., King, D. J. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31661 · Cited by 203
Self-citationDu, Y., Jenkins, N. A., & Copeland, N. G. (2005) · Blood · doi:10.1182/blood-2005-03-1113 · Cited by 189
Recchia, A., Bonini, C., Magnani, Z., Urbinati, F., Sartori, D., Muraro, S., Tagliafico, E., Bondanza, A., Stanghellini, M. T. L., Bernardi, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507496103 · Cited by 189
Calmels, B., Ferguson, C., Laukkanen, M. O., Adler, R. L., Faulhaber, M., Kim, H.-J., Sellers, S. E., Hematti, P., Schmidt, M., Kalle, C. V., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1115 · Cited by 148
Self-citationSchmidt, M., Carbonaro, D., Speckmann, C., Wissler, M., Bohnsack, J., Elder, M., Aronow, B., Nolta, J., Kohn, D., & von Kalle, C. (2003) · Nature Medicine · doi:10.1038/nm844 · Cited by 141
Self-citationNam, C., & Rabbitts, T. H. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.010 · Cited by 122
Comprehensive Genome Sequence Analysis of a Breast Cancer Amplicon
Collins, C. C., Volik, S. V., Kowbel, D., Ginzinger, D. G., Ylstra, B., Cloutier, T., Hawkins, T. L., Predki, P. F., Martin, C., Wernick, M., et al. (2001) · Genome Research · doi:10.1101/gr.gr1743r · Cited by 112
Mooslehner, K. A., Karls, U., & Harbers, K. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.3056-3058.1990 · Cited by 110
Laufs, S. (2002) · Blood · doi:10.1182/blood-2002-02-0627 · Cited by 100
Schmidt, M. (2004) · Blood · doi:10.1182/blood-2004-07-2648 · Cited by 73
Self-citationChromosomes, genes, and development of testicular germ cell tumors
von Eyben, F. E. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2003.09.008 · Cited by 68
Relationship between retroviral DNA-integration-site selection and host cell transcription
Maxfield, L. F., Fraize, C. D., & Coffin, J. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409204102 · Cited by 63
A Model for Predicting the Risk of Cancer Consequent to Retroviral Gene Therapy
Moolten, F. L., & Cupples, L. A. (1992) · Human Gene Therapy · doi:10.1089/hum.1992.3.5-479 · Cited by 53
Cited by
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
“It is striking that, in contrast to the gene therapy developed for SCID, no clonal lymphoproliferation has been reported to date in patients treated for ADA deficiency (36), despite the observation of a similar frequency of integration near LMO2 and other proto-oncogenes (36, 37).”
ResultSelf-citationHowe, S. J., Mansour, M. R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M. H., Pike-Overzet, K., Chatters, S. J., de Ridder, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35798 · Cited by 1,286
Self-citationLentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Biffi, A., Montini, E., Lorioli, L., Cesani, M., Fumagalli, F., Plati, T., Baldoli, C., Martino, S., Calabria, A., Canale, S., et al. (2013) · Science · doi:10.1126/science.1233158 · Cited by 1,180
Self-citationState-of-the-art gene-based therapies: the road ahead
Kay, M. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2971 · Cited by 666
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37630 · Cited by 571
Self-citation
Metadata
- Authors
- Deichmann, A., Hacein-Bey-Abina, S., Schmidt, M., Garrigue, A., Brugman, M. H., Hu, J., Glimm, H., Gyapay, G., Prum, B., Fraser, C. C., Fischer, N., Schwarzwaelder, K., Siegler, M.-L., de Ridder, D., Pike-Overzet, K., Howe, S. J., Thrasher, A. J., Wagemaker, G., Abel, U., Staal, F. J. T., Delabesse, E., Villeval, J.-L., Aronow, B., Hue, C., Prinz, C., Wissler, M., Klanke, C., Weissenbach, J., Alexander, I., Fischer, A., von Kalle, C., & Cavazzana-Calvo, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-08-01
- Volume
- 117
- Issue
- 8
- Pages
- 2225-2232
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1979262175
- Cited by
- 256
- References
- 33
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.